Pharma times RSS Feed

Partnership aims to transform HIV patient care with digital services

Therapy approved for the treatment of paediatric patients with anaplastic large cell lymphoma

Lead asset REX-001 is in Phase III development for chronic limb-threatening ischaemia

Approval is based on results from the Phase III DESTINY-Gastric01 trial

Agreement will leverage Enara's novel Dark Antigen discovery platform

Ensinfentrine is a first-in-class inhaled inhibitor of the enzymes phosphodiesterase 3 and 4

In a Phase IIb trial, more patients experienced complete resolution of hives with ligelizumab compared to Xolair

Zejula has been recommended for use in newly diagnosed ovarian cancer patients

Qualified pharmacists will administer the Pfizer/BioNTech vaccine at an in-store pharmacy

First dispersible tablet formulation of Tivicay now available for children in the EU

Oxford Immunotec will perform T cell testing on participants receiving Valneva's vaccine candidate

Companies will collaborate on a combination therapy study

Updated analysis is from the Phase III IMbrave150 study

MHRA submission is based on same application filed with the EMA

Investigational antibody targets a modified form of beta amyloid called N3pG

First patient in global trial dosed in the UK

Study will evaluate the role of smart devices on monitoring cognitive health

CCS1477 has a novel mechanism of action compared to existing treatments

Framework identifies four key priorities and five 'underpinning themes'

Plan aims to rapidly scale-up COVID-19 vaccination programme